advertisement

WGC-2027

Rojanapongpun P 36

Showing records 1 to 25 | Display all abstracts from Rojanapongpun P

125225 Real-world impact of latanoprostene bunod ophthalmic solution 0.024% in glaucoma therapy: a narrative review
Stamer WD
Frontiers in ophthalmology 2025; 5: 1554777
126386 Optimizing deep learning models for glaucoma screening with vision transformers for resource efficiency and the pie augmentation method
Sangchocanonta S; Sangchocanonta S
PLoS ONE 2025; 20: e0314111
124941 Incidence of and factors associated with brimonidine allergy
Chansangpetch S
PLoS ONE 2025; 20: e0325319
125225 Real-world impact of latanoprostene bunod ophthalmic solution 0.024% in glaucoma therapy: a narrative review
Chiu T
Frontiers in ophthalmology 2025; 5: 1554777
126386 Optimizing deep learning models for glaucoma screening with vision transformers for resource efficiency and the pie augmentation method
Pooprasert P
PLoS ONE 2025; 20: e0314111
124941 Incidence of and factors associated with brimonidine allergy
Pongpisitkul P
PLoS ONE 2025; 20: e0325319
126386 Optimizing deep learning models for glaucoma screening with vision transformers for resource efficiency and the pie augmentation method
Pooprasert P
PLoS ONE 2025; 20: e0314111
124941 Incidence of and factors associated with brimonidine allergy
Tipparut K
PLoS ONE 2025; 20: e0325319
126386 Optimizing deep learning models for glaucoma screening with vision transformers for resource efficiency and the pie augmentation method
Lerthirunvibul N
PLoS ONE 2025; 20: e0314111
125225 Real-world impact of latanoprostene bunod ophthalmic solution 0.024% in glaucoma therapy: a narrative review
Lu DW
Frontiers in ophthalmology 2025; 5: 1554777
126386 Optimizing deep learning models for glaucoma screening with vision transformers for resource efficiency and the pie augmentation method
Patchimnan K
PLoS ONE 2025; 20: e0314111
125225 Real-world impact of latanoprostene bunod ophthalmic solution 0.024% in glaucoma therapy: a narrative review
Wang TH
Frontiers in ophthalmology 2025; 5: 1554777
124941 Incidence of and factors associated with brimonidine allergy
Ratanawongphaibul K
PLoS ONE 2025; 20: e0325319
125225 Real-world impact of latanoprostene bunod ophthalmic solution 0.024% in glaucoma therapy: a narrative review
Rojanapongpun P
Frontiers in ophthalmology 2025; 5: 1554777
124941 Incidence of and factors associated with brimonidine allergy
Itthipanichpong R
PLoS ONE 2025; 20: e0325319
126386 Optimizing deep learning models for glaucoma screening with vision transformers for resource efficiency and the pie augmentation method
Phienphanich P
PLoS ONE 2025; 20: e0314111
124941 Incidence of and factors associated with brimonidine allergy
Manassakorn A
PLoS ONE 2025; 20: e0325319
126386 Optimizing deep learning models for glaucoma screening with vision transformers for resource efficiency and the pie augmentation method
Munthuli A
PLoS ONE 2025; 20: e0314111
125225 Real-world impact of latanoprostene bunod ophthalmic solution 0.024% in glaucoma therapy: a narrative review
Ruangvaravate N
Frontiers in ophthalmology 2025; 5: 1554777
124941 Incidence of and factors associated with brimonidine allergy
Tantisevi V
PLoS ONE 2025; 20: e0325319
126386 Optimizing deep learning models for glaucoma screening with vision transformers for resource efficiency and the pie augmentation method
Puangarom S
PLoS ONE 2025; 20: e0314111
125225 Real-world impact of latanoprostene bunod ophthalmic solution 0.024% in glaucoma therapy: a narrative review
Jo YH
Frontiers in ophthalmology 2025; 5: 1554777
126386 Optimizing deep learning models for glaucoma screening with vision transformers for resource efficiency and the pie augmentation method
Puangarom S
PLoS ONE 2025; 20: e0314111
125225 Real-world impact of latanoprostene bunod ophthalmic solution 0.024% in glaucoma therapy: a narrative review
Moster MR
Frontiers in ophthalmology 2025; 5: 1554777
126386 Optimizing deep learning models for glaucoma screening with vision transformers for resource efficiency and the pie augmentation method
Itthipanichpong R
PLoS ONE 2025; 20: e0314111

Issue 25-2

Change Issue


advertisement

WGA Rescources